Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Fluids and Barriers of the CNS
|
August 30, 2019
Enhanced xeno-free differentiation of hiPSC-derived astroglia applied in a blood-brain barrier model
Louise Delsing, Therése Kallur, Henrik Zetterberg, et al.
Plos One
|
May 17, 2017
Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant
Heike J Wobst, Louise Delsing, Nicholas J Brandon, et al.
Molecular and Cellular Neurosciences
|
July 28, 2020
Models of the blood-brain barrier using iPSC-derived cells
Louise Delsing, Anna Herland, Anna Falk, et al.
Drug Discovery Today
|
November 9, 2024
Immune safety challenges facing the preclinical assessment and clinical progression of cell therapies
Stephanie M Bates, Kelly V Evans, Louise Delsing, et al.
Advanced Drug Delivery Reviews
|
September 26, 2018
Utilizing microphysiological systems and induced pluripotent stem cells for disease modeling: a case study for blood brain barrier research in a pharmaceutical setting
Kristin M Fabre, Louise Delsing, Ryan Hicks, et al.
Neuroscience Letters
|
May 15, 2018
Plasminogen binding inhibitors demonstrate unwanted activities on GABA<sub>A</sub> and glycine receptors in human iPSC derived neurons
Lisbeth Kristensson, Anders Lundin, David Gustafsson, et al.
Regenerative Medicine
|
February 28, 2023
International evaluation study of a highly efficient culture assay for detection of residual human pluripotent stem cells in cell therapies
Takeshi Watanabe, Satoshi Yasuda, Connie L Chen, et al.
Stem Cells (Dayton, Ohio)
|
September 2, 2018
Barrier Properties and Transcriptome Expression in Human iPSC-Derived Models of the Blood-Brain Barrier
Louise Delsing, Pierre Dönnes, José Sánchez, et al.
Frontiers in Molecular Neuroscience
|
March 14, 2017
Cytoplasmic Relocalization of TAR DNA-Binding Protein 43 Is Not Sufficient to Reproduce Cellular Pathologies Associated with ALS <i>In vitro</i>
Heike J Wobst, Steven S Wesolowski, Jayashree Chadchankar, et al.
Stem Cell Reports
|
February 20, 2018
Human iPS-Derived Astroglia from a Stable Neural Precursor State Show Improved Functionality Compared with Conventional Astrocytic Models
Anders Lundin, Louise Delsing, Maryam Clausen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Fluids and Barriers of the CNS
|
August 30, 2019
Enhanced xeno-free differentiation of hiPSC-derived astroglia applied in a blood-brain barrier model
Louise Delsing, Therése Kallur, Henrik Zetterberg, et al.
Plos One
|
May 17, 2017
Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant
Heike J Wobst, Louise Delsing, Nicholas J Brandon, et al.
Molecular and Cellular Neurosciences
|
July 28, 2020
Models of the blood-brain barrier using iPSC-derived cells
Louise Delsing, Anna Herland, Anna Falk, et al.
Drug Discovery Today
|
November 9, 2024
Immune safety challenges facing the preclinical assessment and clinical progression of cell therapies
Stephanie M Bates, Kelly V Evans, Louise Delsing, et al.
Advanced Drug Delivery Reviews
|
September 26, 2018
Utilizing microphysiological systems and induced pluripotent stem cells for disease modeling: a case study for blood brain barrier research in a pharmaceutical setting
Kristin M Fabre, Louise Delsing, Ryan Hicks, et al.
Neuroscience Letters
|
May 15, 2018
Plasminogen binding inhibitors demonstrate unwanted activities on GABA<sub>A</sub> and glycine receptors in human iPSC derived neurons
Lisbeth Kristensson, Anders Lundin, David Gustafsson, et al.
Regenerative Medicine
|
February 28, 2023
International evaluation study of a highly efficient culture assay for detection of residual human pluripotent stem cells in cell therapies
Takeshi Watanabe, Satoshi Yasuda, Connie L Chen, et al.
Stem Cells (Dayton, Ohio)
|
September 2, 2018
Barrier Properties and Transcriptome Expression in Human iPSC-Derived Models of the Blood-Brain Barrier
Louise Delsing, Pierre Dönnes, José Sánchez, et al.
Frontiers in Molecular Neuroscience
|
March 14, 2017
Cytoplasmic Relocalization of TAR DNA-Binding Protein 43 Is Not Sufficient to Reproduce Cellular Pathologies Associated with ALS <i>In vitro</i>
Heike J Wobst, Steven S Wesolowski, Jayashree Chadchankar, et al.
Stem Cell Reports
|
February 20, 2018
Human iPS-Derived Astroglia from a Stable Neural Precursor State Show Improved Functionality Compared with Conventional Astrocytic Models
Anders Lundin, Louise Delsing, Maryam Clausen, et al.
Page
of 2